Meropenem Steriscience (Meropenem Trihydrate)

Meropenem is a carbapenem antibiotic used for severe bacterial infections affecting various organ systems.

• Complicated intra‑abdominal infections: achieves bacterial eradication and clinical cure in patients with intra‑abdominal sepsis.
• Complicated urinary tract infections: provides effective treatment of resistant Gram‑negative uropathogens.
• Bacterial meningitis: penetrates the cerebrospinal fluid to eradicate causative organisms.
• Severe pneumonia: offers broad‑spectrum coverage against typical and atypical pathogens.
• Sepsis: delivers rapid bactericidal activity in systemic infections.

• Meropenem binds with high affinity to penicillin‑binding proteins (PBPs) on bacterial cell walls, inhibiting the final transpeptidation step of peptidoglycan synthesis. This disruption weakens the cell wall, leading to osmotic instability, cell lysis, and bacterial death. Its broad spectrum includes many Gram‑negative, Gram‑positive and anaerobic organisms, and it is resistant to most β‑lactamases. The drug is time‑dependent, requiring prolonged exposure above the minimum inhibitory concentration for optimal effect.

Meropenem may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects

• Diarrhea: mild to moderate loose stools.
• Nausea: occasional feeling of queasiness.
• Rash: transient skin erythema.
• Elevated liver enzymes: mild transaminase increase.
• Headache: occasional mild headache.
• Injection site pain: discomfort at the IV site.
• Fever: low‑grade temperature rise.

Serious or Rare Side Effects

• Seizures: especially in patients with renal impairment.
• Severe allergic reactions: anaphylaxis or Stevens‑Johnson syndrome.
• Clostridioides difficile colitis: antibiotic‑associated diarrhea.
• Thrombocytopenia: low platelet count.
• Renal dysfunction: acute kidney injury.
• Hypotension: sudden drop in blood pressure.

When using Meropenem, clinicians should consider several precautionary measures to ensure safe therapy.

• Renal function: adjust dose in patients with impaired renal function.
• Hepatic function: monitor liver enzymes during prolonged therapy.
• Seizure risk: avoid in patients with a history of seizures or CNS disorders.
• Antibiotic stewardship: limit use to confirmed or strongly suspected bacterial infections to reduce resistance.
• Drug hypersensitivity: assess for β‑lactam allergy before administration.
• Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Meropenem can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid)

• Valproic acid: may reduce serum valproate levels, risking seizure breakthrough.
• Probenecid: can increase meropenem concentrations, raising toxicity risk.

Moderate Interactions (Monitor Closely)

• Aminoglycosides: concurrent use may increase nephrotoxicity; monitor renal function.
• Loop diuretics: may enhance ototoxic potential when combined with other ototoxic agents.
• Anticoagulants: may potentiate bleeding; check coagulation parameters.
• Oral contraceptives: possible reduction in effectiveness; advise alternative contraception.
• Cefepime: additive neurotoxicity risk; monitor neurological status.
• Immunosuppressants: may increase infection risk; observe for opportunistic infections.